In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed the day trading at $10.16 down -1.45% from the previous closing price of $10.31. In other words, the price has decreased by -$1.45 from its previous closing price. On the day, 1.43 million shares were traded. RCKT stock price reached its highest trading level at $10.5699 during the session, while it also had its lowest trading level at $10.1.
Ratios:
For a better understanding of RCKT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.05 and its Current Ratio is at 6.05. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on December 30, 2024, initiated with a Outperform rating and assigned the stock a target price of $32.
On December 18, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $29.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’24 when Militello John sold 1,224 shares for $13.05 per share. The transaction valued at 15,978 led to the insider holds 49,310 shares of the business.
Patel Kinnari sold 4,588 shares of RCKT for $59,892 on Nov 21 ’24. The insider now owns 392,395 shares after completing the transaction at $13.05 per share. On Nov 21 ’24, another insider, Shah Gaurav, who serves as the CEO of the company, sold 11,091 shares for $13.05 each. As a result, the insider received 144,782 and left with 707,328 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 1096335104 and an Enterprise Value of 716136000.
Stock Price History:
Over the past 52 weeks, RCKT has reached a high of $31.47, while it has fallen to a 52-week low of $10.12. The 50-Day Moving Average of the stock is -22.19%, while the 200-Day Moving Average is calculated to be -46.23%.
Shares Statistics:
Over the past 3-months, RCKT traded about 1.26M shares per day on average, while over the past 10 days, RCKT traded about 1728360 shares per day. A total of 106.34M shares are outstanding, with a floating share count of 98.21M. Insiders hold about 7.64% of the company’s shares, while institutions hold 84.99% stake in the company. Shares short for RCKT as of 1735603200 were 12927098 with a Short Ratio of 10.24, compared to 1732838400 on 10386199. Therefore, it implies a Short% of Shares Outstanding of 12927098 and a Short% of Float of 22.209999.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 13.0 analysts currently analyzing and rating the stock of Rocket Pharmaceuticals Inc (RCKT).The consensus estimate for the next quarter is -$0.7, with high estimates of -$0.59 and low estimates of -$0.83.
Analysts are recommending an EPS of between -$2.45 and -$2.95 for the fiscal current year, implying an average EPS of -$2.81. EPS for the following year is -$2.4, with 15.0 analysts recommending between -$0.68 and -$3.2.
